Thioguanosine

Thioguanosine

SCHEMBL10017757

Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@H](O)C2O)c(=S)[nH]1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.62
▸ NT5E P21589 1/20 0.62
▸ HIF1A Q16665 1/20 0.62
▸ ADORA2A P29274 5/20 0.61
▸ ADORA2B P29275 4/20 0.61
▸ CYP2C19 P33261 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ ADORA3 P0DMS8 3/20 0.60
▸ ADORA1 P30542 2/20 0.60
▸ DPP4 P27487 1/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ SLC28A1 O00337 1/20 0.60
▸ MAP3K7 O43318 1/20 0.60
▸ SLC28A2 O43868 1/20 0.60
▸ GAPDH P04406 1/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ STAT6 P42226 1/20 0.60
▸ PI4KA P42356 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thioguanosine SCHEMBL4527568 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL9791201 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL5557152 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL230739 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL230740 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL2619736 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL4527562 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL1981035 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL14156817 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B
Thioguanosine SCHEMBL18249513 1.00 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114986-B2 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation GIULIANI INTERNATIONAL LIMITED (IE) 2012-02-14 — — US disclosed
US-20100323980-A9 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation NOGRA PHARMA LIMITED (IE) 2010-12-23 — — US disclosed
US-20090258837-A1 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation GIULIANI INTERNATIONAL LIMITED (IE) 2009-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258837-A1 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation TPMT, MTAP, G6PD LMNA 4630/4885NT5E 209/4885HIF1A 616/4885
US-20100323980-A9 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation TPMT, G6PD, MTAP LMNA 4616/4885NT5E 257/4885HIF1A 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback